Lefa Alksne

15 papers receiving 751 citations

Peers

Lefa Alksne
Comparison fields: 5 of 71
  • Molecular Medicine 94
  • Endocrinology 64
  • Molecular Biology 640
  • Microbiology 41
  • Infectious Diseases 106
Replace Daryl L. Richie with:
Daryl L. Richie United States
Akira Iwata Japan
Kristin J. Pederson United States
Veronica G. Godoy United States
C. N. Kwan United States
TuAnh N. Huynh United States
Kathrin Nowak Germany
Mee‐Ngan F. Yap United States
Jacques J. Pène United States
Julia P. Deisinger Germany
Lefa Alksne relative to Daryl L. Richie United States Daryl L. Richie's profile →
Citations per field
00.5×1.7×
Daryl L. Richie · 1×
Citations per year

Countries citing papers authored by Lefa Alksne

Since Specialization
Citations

This map shows the geographic impact of Lefa Alksne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lefa Alksne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lefa Alksne more than expected).

Fields of papers citing papers by Lefa Alksne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lefa Alksne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lefa Alksne. The network helps show where Lefa Alksne may publish in the future.

Co-authors

The 25 scholars most cited alongside Lefa Alksne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lefa Alksne Line = papers co-authored together Lefa Alksne links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 2003142
2 2002138
3 2000125
4 199394
5 199764
6 199646
7 200042
8 200226
9 200225
10 199518
11 199318
12 200617
13 200813
14 199210
15
Balofloxacin Choongwae.
20033

About Lefa Alksne

Lefa Alksne is a scholar working on Molecular Medicine, Endocrinology, Molecular Biology, Clinical Biochemistry and Genetics, having authored 15 papers that have together received 781 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (5 papers), Antibiotic Resistance in Bacteria (5 papers), Biochemical and Structural Characterization (4 papers), Bacterial Genetics and Biotechnology (4 papers), RNA modifications and cancer (3 papers), Glycosylation and Glycoproteins Research (3 papers), Bacterial biofilms and quorum sensing (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Molecular Medicine (94 citations), Endocrinology (64 citations), Molecular Biology (640 citations), Microbiology (41 citations) and Infectious Diseases (106 citations). Lefa Alksne has collaborated with scholars based in United States, France and Greece. Frequent co-authors include Steven J. Projan, B A Rasmussen, Jonathan R. Warner, Olaf Schneewind, Sarkis K. Mazmanian, Hung Ton‐That, Susan W. Liebman, Ann Aulabaugh, George A. Ellestad and Xinyi Huang. Their work appears in journals such as Journal of Bacteriology, Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy, Biochemistry and Current Pharmaceutical Design.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026